Stem cell researches in Brazil: present and future challenges.

Area of Science:

• Regenerative Medicine
• Stem Cell Biology
• Clinical Translation

Background:

• Brazil's legal framework for stem cell research evolved, with human embryonic stem cell (hESC) research approved later than adult stem cell (ASC) research.
• Extensive research with ASCs in vitro, animal models, and clinical trials has been ongoing in Brazil for years.

Purpose of the Study:

• To summarize key findings from Brazilian stem cell research, particularly concerning adult stem cells.
• To outline the challenges in translating stem cell research from the laboratory ('bench') to clinical application ('bed').
• To highlight the importance of publishing negative experimental results.

Main Methods:

• Review of existing research findings on adult stem cells in Brazil.
• Analysis of challenges in the bench-to-bedside translation process.
• Emphasis on the significance of reporting negative trial outcomes.

Main Results:

• Ongoing progress in adult stem cell research across various therapeutic areas in Brazil.
• Identification of significant hurdles in clinical translation for conditions like heart disease, diabetes, cancer, craniofacial, and neuromuscular disorders.
• Recognition of the critical need for publishing negative results to guide future research and protect patients.

Conclusions:

• Adult stem cell research in Brazil shows promise but faces translation challenges.
• Publishing negative results is crucial for scientific integrity, efficiency, and patient welfare.
• Continued investigation and transparent reporting are vital for advancing regenerative medicine.